News
SGFEF
730.00
NaN%
--
Siegfried downgraded to Neutral from Buy at UBS
TipRanks · 06/16 08:55
Siegfried boosts global API network with new large-scale Minden facility
TipRanks · 06/16 05:02
Siegfried names Christina Del Vecchio Chief Legal Officer as long‑time legal head departs
TipRanks · 06/01 05:02
Siegfried Raises CHF 200 Million Via Bond Issue to Fund Growth
TipRanks · 05/26 12:48
Analysts Have Conflicting Sentiments on These Healthcare Companies: Altimmune (ALT), Nuwellis (NUWE) and Siegfried Holding AG (OtherSGFEF)
TipRanks · 05/14 12:20
Siegfried Rejoins Dow Jones Best-in-Class Europe Index as Sole End-to-End CDMO
TipRanks · 05/07 05:02
Siegfried price target raised to CHF 109 from CHF 105 at Deutsche Bank
TipRanks · 04/29 15:57
Siegfried’s DINAMIQS Wins Swissmedic License, Expanding Viral Vector CDMO Capabilities
TipRanks · 04/29 05:02
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Medpace Holdings (MEDP), Siegfried Holding AG (OtherSGFEF) and Edwards Lifesciences (EW)
TipRanks · 04/26 12:21
Siegfried Wins Antitrust Nod for US–Australia Plant Deal and Lifts 2026 Growth Outlook
TipRanks · 04/24 05:03
Siegfried Shareholders Back Capital Reduction and New Board Leadership at AGM
TipRanks · 04/16 13:35
Analysts Offer Insights on Healthcare Companies: Siegfried Holding AG (OtherSGFEF) and Nyxoah (NYXH)
TipRanks · 03/22 01:40
Siegfried price target lowered to CHF 96 from CHF 108 at RBC Capital
TipRanks · 03/16 17:40
Analysts Offer Insights on Healthcare Companies: Siegfried Holding AG (OtherSGFEF), Oruka Therapeutics (ORKA) and Globus Medical (GMED)
TipRanks · 03/16 07:22
Siegfried Holding AG Delivers Record Margins Amid Expansion
TipRanks · 02/24 00:23
Siegfried Holding AG (SGFEF) Receives a Buy from UBS
TipRanks · 02/23 09:37
Kepler Capital Remains a Hold on Siegfried Holding AG (SGFEF)
TipRanks · 02/22 01:48
Siegfried lifts profitability and expands U.S. footprint amid cautious 2026 outlook
TipRanks · 02/20 06:03
S&P Futures Muted With U.S. PCE Inflation and GDP Data in Focus
Barchart · 02/20 05:26
Siegfried downgraded to Sector Perform from Outperform at RBC Capital
TipRanks · 02/12 09:50
More
Webull provides a variety of real-time SGFEF stock news. You can receive the latest news about Siegfried Hldg Ltd through multiple platforms. This information may help you make smarter investment decisions.
About SGFEF
Siegfried Holding AG is a Switzerland-based life sciences company which is active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and sterile. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States, China, and Spain.